Advocacy & News

Federal and Regulatory Outreach

AMRPA Submits Comments re: CY 2022 Home Health Prospective Payment System proposed rule

Thursday, August 26, 2021

Regulatory #COVID19 IRF-PAI

AMRPA Submits Comments to CMS: re FY 2022 IRF PPS Proposed Rule

Friday, June 4, 2021

Regulatory IRF PPS IRF

AMRPA & NALTH Send Joint Response to CMS on Medicare Advantage Prior Authorization Issues during the Public Health Emergency

Thursday, March 18, 2021

Regulatory Medicare Advantage Prior Authorization

AMRPA’s Comment Letter on the CMS Proposed IRF Review Choice Demonstration

Wednesday, February 17, 2021

AMRPA Second Round Comment Letter to NQF on IRF Measure Under Consideration

Tuesday, January 19, 2021

AMRPA Comment Letter to NQF on IRF Measure Under Consideration

Wednesday, January 6, 2021

AMRPA Responds to MedPAC December 2020 Session on IRF Payment Adequacy and Access

Tuesday, December 29, 2020

Regulatory Medicare Advantage #COVID19

AMRPA Submits Comments on HHS RFI on COVID-19 Regulatory Changes

Monday, December 28, 2020

Regulatory Prior Authorization IRF COVID-19

AMRPA Statement on Proposed CMS IRF Choice Review Demonstration ‎

Tuesday, December 15, 2020

AMRPA & NALTH Send Joint Letter to CMS on Medicare Advantage Prior Authorization

Wednesday, December 9, 2020

Regulatory Medicare Advantage Prior Authorization

AMRPA Submits Comment to CMS on CY 2022 Medicare Advantage and Part D Advance Notice Parts I and II

Monday, November 30, 2020

Regulatory Medicare Advantage

AMRPA Submits comments on MCIT Pathway and Definition of "Reasonable and Necessary"

Monday, November 2, 2020

AMRPA Submits Comments on CY 2021 Medicare Physician Fee Schedule and Quality Payment Program Proposed Rule

Tuesday, October 6, 2020

Regulatory Physician Fee Schedule Quality Payment Program

DRRC Letter to HHS in Support for Federal Investment into COVID-19 Research on Disability, Independent Living and Rehabilitation

Tuesday, September 8, 2020

Regulatory COVID-19

AMRPA’s Response to the CMS Proposed Rule on Inpatient Prospective Payment System for FY 2021

Friday, July 10, 2020

Regulatory IPPS/LTCH PPS

AMRPA’s Submissions to the CMS Interim Final Rule on COVID-19

Thursday, July 9, 2020

Regulatory #COVID19 COVID-19

AMRPA Submits Comments on Fiscal Year 2021 Inpatient Rehabilitation Facility Prospective Payment System Proposed Rule

Friday, June 5, 2020

Regulatory IRF PPS

AMRPA Responds to Proposed Rules on Anti-Kickback Statute and Physician Self-Referral Regulations

Tuesday, December 31, 2019

Regulatory burden reduction

AMRPA Response to Rural & Underserved Communities Task Force RFI

Friday, November 29, 2019

Regulatory Medicare Advantage Telehealth

AMRPA Opposes Recently Finalized Hospital Pricing Regulations

Tuesday, November 26, 2019

Regulatory burden reduction

Interested in Becoming a Part of AMRPA?

AMRPA is the nation’s only trade organization dedicated solely to the interests of inpatient rehabilitation and represents more than 650 freestanding rehabilitation hospitals and rehabilitation units of general hospitals. Fill out a membership application today!